A QTc study of cabazitaxel in patients with advanced solid tumors

被引：0
|
作者：
Wade, James Lloyd
Dakhil, Shaker R.
Baron, Ari David
Rottey, Sylvie
Millard, Frederick E.
Daugaard, Gedske
Machiels, Jean-Pascal H.
Conkright, William A.
Sharma, Sunil
Soetekouw, Patricia M. M. B.
Yachnin, Jeffrey
Sengelov, Lisa
van Veldhuizen, Peter
Agarwala, Sanjiv S.
Nguyen, T. X. Quyen
Chadjaa, Mustapha
Maison-Blanche, Pierre
机构：
[1] Canc Care Specialists Cent Illinois, Decatur, IL USA
[2] Canc Ctr Kansas, Wichita, KS USA
[3] Calif Pacific Med Ctr, San Francisco, CA USA
[4] Ghent Univ Hosp, Ghent, Belgium
[5] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
[6] Rigshosp, DK-2100 Copenhagen, Denmark
[7] Catholic Univ Louvain, Ctr Canc, B-1200 Brussels, Belgium
[8] Purchase Canc Grp, Paducah, KY USA
[9] Huntsman Canc Inst, Salt Lake City, UT USA
[10] Univ Hosp Maastricht, Maastricht, Netherlands
[11] Univ Uppsala Hosp, Dept Oncol, S-75185 Uppsala, Sweden
[12] Herlev Hosp, DK-2730 Herlev, Denmark
[13] Kansas City Vet Adm Med Ctr, Kansas City, MO USA
[14] St Lukes Canc Ctr, Bethlehem, PA USA
[15] Sanofi, Paris, France
[16] Hop Lariboisiere, F-75475 Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.257
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
257
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PHASE I STUDY OF CABAZITAXEL IN PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY SOLID TUMORS: A POETIC GROUP STUDY
    Manley, P.
    Trippett, T.
    Smith, A.
    Macy, M.
    Leary, S.
    Boklan, J.
    Cohen, K.
    Shen, L.
    Herzog, C.
    Veyrat-Follet, C.
    Zhang, J.
    Chi, S.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S157 - S158
  • [22] Electrocardiographic Characterization of the QTc Interval in Patients with Advanced Solid Tumors: Pharmacokinetic-Pharmacodynamic Evaluation of Sunitinib
    Bello, Carlo L.
    Mulay, Marilyn
    Huan, Xin
    Patyna, Shem
    Dinolfo, Melissa
    Levine, Steven
    Van Vugt, Andrew
    Toh, Melvin
    Baum, Charles
    Rosen, Lee
    CLINICAL CANCER RESEARCH, 2009, 15 (22) : 7045 - 7052
  • [23] Pharmacokinetic Study of Rucaparib in Patients With Advanced Solid Tumors
    Shapiro, Geoffrey, I
    Kristeleit, Rebecca S.
    Burris, Howard A.
    LoRusso, Patricia
    Patel, Manish R.
    Drew, Yvette
    Giordano, Heidi
    Maloney, Lara
    Watkins, Simon
    Goble, Sandra
    Jaw-Tsai, Sarah
    Xiao, Jim J.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (01): : 107 - 118
  • [24] Phase I study of cabazitaxel plus cisplatin in patients with advanced solid tumors: study to evaluate the impact of cytochrome P450 3A inhibitors (aprepitant, ketoconazole) or inducers (rifampin) on the pharmacokinetics of cabazitaxel
    John Sarantopoulos
    Alain C. Mita
    James L. Wade
    John C. Morris
    Olivier Rixe
    Monica M. Mita
    Jean-François Dedieu
    Claudine Wack
    Laurent Kassalow
    A. Craig Lockhart
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 1113 - 1124
  • [25] Characterization of electrocardiographic QTc interval in patients (pts) with advanced solid tumors: pharmacokinetic-pharmacodynamic evaluation of sunitinib
    Bello, C. L.
    Rosen, L. S.
    Mulay, M.
    Van Vugt, A.
    Dinolfo, M.
    Levine, S.
    Huang, X.
    Fingert, H. J.
    Toh, M.
    Baum, C. M.
    EJC SUPPLEMENTS, 2007, 5 (04): : 110 - 110
  • [26] Assessment of the effect of erdafitinib on cardiac safety: analysis of ECGs and exposure–QTc in patients with advanced or refractory solid tumors
    Elodie Valade
    Anne-Gaëlle Dosne
    Hong Xie
    Robert Kleiman
    Lilian Y. Li
    Juan José Perez-Ruixo
    Daniele Ouellet
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 621 - 633
  • [27] Phase I study of cabazitaxel plus cisplatin in patients with advanced solid tumors: study to evaluate the impact of cytochrome P450 3A inhibitors (aprepitant, ketoconazole) or inducers (rifampin) on the pharmacokinetics of cabazitaxel
    Sarantopoulos, John
    Mita, Alain C.
    Wade, James L.
    Morris, John C.
    Rixe, Olivier
    Mita, Monica M.
    Dedieu, Jean-Francois
    Wack, Claudine
    Kassalow, Laurent
    Lockhart, A. Craig
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (06) : 1113 - 1124
  • [28] Phase I study of camrelizumab in patients with advanced solid tumors
    Yuxiang Ma
    Jiaxin Cao
    Yang Zhang
    Qianwen Liu
    Wenfeng Fang
    Yunpeng Yang
    Yuanyuan Zhao
    Qing Yang
    Hongyun Zhao
    Li Zhang
    Signal Transduction and Targeted Therapy, 8
  • [29] Pharmacodynamic and safety study of reolysin in patients with advanced solid tumors
    Gollamudi, R.
    Desai, K.
    Chaudhary, I.
    Ghalib, M. H.
    Wong, B.
    Einstein, M.
    Coffey, M.
    Gill, G.
    Mani, S.
    Goel, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] Phase I study of camrelizumab in patients with advanced solid tumors
    Ma, Yuxiang
    Cao, Jiaxin
    Zhang, Yang
    Liu, Qianwen
    Fang, Wenfeng
    Yang, Yunpeng
    Zhao, Yuanyuan
    Yang, Qing
    Zhao, Hongyun
    Zhang, Li
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
12345